Masahiro Suyama
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Masahiro Suyama has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
Takashi Yokoo
Division of Nephrology and Hypertension, Department of Internal Medicine, Jikei University School of medicine, Tokyo, Japan
3 shared publicationsMakoto Ogura
Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, Tokyo, 105-8461, Japan
2 shared publications- Masato Ikeda
The Jikei University School of Medicine
2 shared publications - Nobuo Tsuboi
Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
2 shared publications Tetsuya Kawamura
Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, Tokyo, 105-8461, Japan
2 shared publicationsYoichi Miyazaki
Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
2 shared publications
Latest Publications
- Open Access
- 19 March 2025
- Published by Wolters Kluwer Health in Kidney360
- Vol. 6 (7) , 1106-1115
The Cardio-Ankle Vascular Index Predicts Long-Term Kidney Prognosis in Nondiabetic CKD Patients Who Underwent Kidney Biopsy
Key Points: Cardio-Ankle Vascular Index (CAVI) is a known predictor of cardiovascular events; however, few studies have considered kidney prognosis. CAVI at the time of kidney biopsy was independently associated with long-term kidney prognosis in patients without diabetes. The CAVI cutoff value at the time of kidney biopsy for predicting future eGFR decline of ≥30% or ESKD was 7.7. Background: The Cardio-Ankle Vascular Index (CAVI) is a noninvasive index of arterial stiffness that is independent of BP at the time of measurement. Although the role of CAVI as a predictor of cardiovascular events has been reported, few studies have considered kidney prognosis. This study investigated the association between CAVI and long-term kidney prognosis in patients with nondiabetic CKD who underwent kidney biopsy. Methods: This study was a longitudinal, observational, single-center study of patients with CKD stages 1–4 and follow-up ≥1 year who had CAVI measured at the time of kidney biopsy. The primary outcome was a 30% decline in the eGFR from baseline or ESKD. Results: Forty-six patients (mean age, 53 years; median eGFR, 61.5 ml/min per 1.73 m2; median follow-up period, 98 months) were enrolled. Eighteen patients achieved the primary outcome and a higher CAVI was significantly associated with this outcome. Multivariate analyses consistently identified CAVI as an independent factor associated with the outcome. Using receiver-operating characteristic curve analysis, the cutoff value for CAVI was 7.7 (sensitivity, 78%; specificity, 79%). Kaplan–Meier analysis showed significantly lower outcome-free survival in the CAVI ≥7.7 group than in the CAVI <7.7 group. No consistent trend was observed between kidney histopathology and CAVI. Conclusions: CAVI at the time of kidney biopsy is independently associated with long-term kidney prognosis in patients with nondiabetic CKD.
- 19 March 2025
- Published by Wolters Kluwer Health in Kidney360
- Vol. 6 (7) , 1106-1115
Open AccessThe Cardio-Ankle Vascular Index Predicts Long-Term Kidney Prognosis in Nondiabetic CKD Patients Who Underwent Kidney Biopsy
Key Points: Cardio-Ankle Vascular Index (CAVI) is a known predictor of cardiovascular events; however, few studies have considered kidney prognosis. CAVI at the time of kidney biopsy was independently associated with long-term kidney prognosis in patients without diabetes. The CAVI cutoff value at the time of kidney biopsy for predicting future eGFR decline of ≥30% or ESKD was 7.7. Background: The Cardio-Ankle Vascular Index (CAVI) is a noninvasive index of arterial stiffness that is independent of BP at the time of measurement. Although the role of CAVI as a predictor of cardiovascular events has been reported, few studies have considered kidney prognosis. This study investigated the association between CAVI and long-term kidney prognosis in patients with nondiabetic CKD who underwent kidney biopsy. Methods: This study was a longitudinal, observational, single-center study of patients with CKD stages 1–4 and follow-up ≥1 year who had CAVI measured at the time of kidney biopsy. The primary outcome was a 30% decline in the eGFR from baseline or ESKD. Results: Forty-six patients (mean age, 53 years; median eGFR, 61.5 ml/min per 1.73 m2; median follow-up period, 98 months) were enrolled. Eighteen patients achieved the primary outcome and a higher CAVI was significantly associated with this outcome. Multivariate analyses consistently identified CAVI as an independent factor associated with the outcome. Using receiver-operating characteristic curve analysis, the cutoff value for CAVI was 7.7 (sensitivity, 78%; specificity, 79%). Kaplan–Meier analysis showed significantly lower outcome-free survival in the CAVI ≥7.7 group than in the CAVI <7.7 group. No consistent trend was observed between kidney histopathology and CAVI. Conclusions: CAVI at the time of kidney biopsy is independently associated with long-term kidney prognosis in patients with nondiabetic CKD.
- Open Access
- 16 March 2019
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 23 (7) , 928-938
Negative impact of proteinuria on circulating myeloid dendritic cells
A decrease in absolute numbers (abs.) of circulating dendritic cells (DCs) and recruitment into target organs has been reported, but whether the level of proteinuria associates with circulating DC abs. has not been clarified.
- 16 March 2019
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 23 (7) , 928-938
Open AccessNegative impact of proteinuria on circulating myeloid dendritic cells
A decrease in absolute numbers (abs.) of circulating dendritic cells (DCs) and recruitment into target organs has been reported, but whether the level of proteinuria associates with circulating DC abs. has not been clarified.
- 3 August 2017
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 22 (2) , 266-274
Forced expression of vascular endothelial growth factor-A in podocytes decreases mesangial cell numbers and attenuates endothelial cell differentiation in the mouse glomerulus
Background Glomerular podocyte-derived vascular endothelial growth factor (VEGF) is indispensable for the migration and proliferation of glomerular endothelial cells. In contrast, podocyte-specific Vegf overexpression leads to the collapse of glomerular tufts; however, the mechanisms underlying this outcome have not yet been reported. Methods To further clarify the effects of elevated levels of Vegf expression on glomerular cells, we established a dual transgenic mouse line in which Vegf was exclusively and inducibly expressed in podocytes under the control of the “Tet-on system” (Podocin-rtTA/TetO-Vegf164 mice). Results Macroscopic and microscopic examination of Podocin-rtTA/TetO-Vegf164 animals following Vegf induction identified the presence of prominent red bloody spots. In addition, the endothelial cell number was increased along with enlargement of the subendothelial spaces. We also observed impaired endothelial fenestrations and aberrant plasmalemmal vesicle-associated protein-1 (PV-1) expression. In contrast, the mesangial cell number markedly decreased, resulting in a glomerular tuft intussusceptive splitting defect. Furthermore, whereas platelet-derived growth factor-B (PDGF-B) expression in the glomerular cells of Podocin-rtTA/TetO-Vegf164 mice was not decreased, phospho-PDGF receptor immunoreactivity in the mesangial cells was significantly decreased when compared to wild-type animals. Conclusion Taken together, the results of this study indicated that the upregulation of podocyte VEGF decreased the number of mesangial cells, likely owing to inhibition of PDGF-B-mediated signaling.
- 3 August 2017
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 22 (2) , 266-274
Forced expression of vascular endothelial growth factor-A in podocytes decreases mesangial cell numbers and attenuates endothelial cell differentiation in the mouse glomerulus
Background Glomerular podocyte-derived vascular endothelial growth factor (VEGF) is indispensable for the migration and proliferation of glomerular endothelial cells. In contrast, podocyte-specific Vegf overexpression leads to the collapse of glomerular tufts; however, the mechanisms underlying this outcome have not yet been reported. Methods To further clarify the effects of elevated levels of Vegf expression on glomerular cells, we established a dual transgenic mouse line in which Vegf was exclusively and inducibly expressed in podocytes under the control of the “Tet-on system” (Podocin-rtTA/TetO-Vegf164 mice). Results Macroscopic and microscopic examination of Podocin-rtTA/TetO-Vegf164 animals following Vegf induction identified the presence of prominent red bloody spots. In addition, the endothelial cell number was increased along with enlargement of the subendothelial spaces. We also observed impaired endothelial fenestrations and aberrant plasmalemmal vesicle-associated protein-1 (PV-1) expression. In contrast, the mesangial cell number markedly decreased, resulting in a glomerular tuft intussusceptive splitting defect. Furthermore, whereas platelet-derived growth factor-B (PDGF-B) expression in the glomerular cells of Podocin-rtTA/TetO-Vegf164 mice was not decreased, phospho-PDGF receptor immunoreactivity in the mesangial cells was significantly decreased when compared to wild-type animals. Conclusion Taken together, the results of this study indicated that the upregulation of podocyte VEGF decreased the number of mesangial cells, likely owing to inhibition of PDGF-B-mediated signaling.
- 21 July 2017
- Published by Springer Nature in Annals of Hematology
- Vol. 96 (9) , 1517-1523
Clinical impact of pre-transplant gut microbial diversity on outcomes of allogeneic hematopoietic stem cell transplantation
Post-transplant microbial diversity in the gastrointestinal tract is closely associated with clinical outcomes following allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, little is known about the impact of the fecal microbiota before allo-HSCT. We analyzed fecal samples approximately 2 weeks before conditioning among 107 allo-HSCT recipients between 2013 and 2015. Microbial analysis was performed using 16S rRNA gene sequencing. Operational taxonomic unit-based microbial diversity was estimated by calculating the Shannon index. Patients were classified into three groups based on the diversity index: low (3) diversity (18 (16.8%), 48 (44.9%), and 41 (38.3%) patients, respectively). There were no significant differences in the 20-month overall survival, cumulative incidence of relapse, and non-relapse mortality among three groups. The cumulative incidence of grade II to IV acute graft-versus-host disease (aGVHD) was similar among the three groups (low 55.6%; intermediate 35.4%; high 48.8%, p = 0.339, at day 100). Furthermore, we found no differences in the cumulative incidence of grade II to IV acute gastrointestinal GVHD among the three groups (low 38.9%; intermediate 21.3%; high 24.4%, p = 0.778, at day 100). Regarding the composition of microbiota before allo-HSCT, aGVHD patients showed a significantly higher abundance of phylum Firmicutes (p < 0.01) and a lower tendency for Bacteroidetes (p = 0.106) than non-aGVHD patients. Maintenance of Bacteroidetes throughout allo-HSCT may be a strategy to prevent aGVHD.
- 21 July 2017
- Published by Springer Nature in Annals of Hematology
- Vol. 96 (9) , 1517-1523
Clinical impact of pre-transplant gut microbial diversity on outcomes of allogeneic hematopoietic stem cell transplantation
Post-transplant microbial diversity in the gastrointestinal tract is closely associated with clinical outcomes following allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, little is known about the impact of the fecal microbiota before allo-HSCT. We analyzed fecal samples approximately 2 weeks before conditioning among 107 allo-HSCT recipients between 2013 and 2015. Microbial analysis was performed using 16S rRNA gene sequencing. Operational taxonomic unit-based microbial diversity was estimated by calculating the Shannon index. Patients were classified into three groups based on the diversity index: low (3) diversity (18 (16.8%), 48 (44.9%), and 41 (38.3%) patients, respectively). There were no significant differences in the 20-month overall survival, cumulative incidence of relapse, and non-relapse mortality among three groups. The cumulative incidence of grade II to IV acute graft-versus-host disease (aGVHD) was similar among the three groups (low 55.6%; intermediate 35.4%; high 48.8%, p = 0.339, at day 100). Furthermore, we found no differences in the cumulative incidence of grade II to IV acute gastrointestinal GVHD among the three groups (low 38.9%; intermediate 21.3%; high 24.4%, p = 0.778, at day 100). Regarding the composition of microbiota before allo-HSCT, aGVHD patients showed a significantly higher abundance of phylum Firmicutes (p < 0.01) and a lower tendency for Bacteroidetes (p = 0.106) than non-aGVHD patients. Maintenance of Bacteroidetes throughout allo-HSCT may be a strategy to prevent aGVHD.
- Open Access
- 27 January 2015
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 28 (9) , 1164-1171
Glomerular Density in Biopsy-Proven Hypertensive Nephrosclerosis
Previous autopsy studies suggested that a reduced nephron number is associated with increased risk of hypertension and chronic kidney disease. However, the significance of the nephron number estimated from a renal biopsy in patients with hypertensive nephrosclerosis (HNS) has not yet been elucidated. In this cross-sectional study, we examined the clinicopathological findings of biopsy-proven HNS patients with preserved renal function (estimated glomerular filtration rate ≥ 60ml/min/1.73 m2). The glomerular density (GD; the number of glomeruli per total renal cortical area) in biopsy specimens was evaluated as a surrogate of the nephron number. Renal biopsies from kidney transplant donors were used as healthy controls. A total of 58 HNS patients were enrolled. The GD value in the HNS patients was low compared with those in the kidney transplant donors (2.0 vs. 3.2 /mm2). These differences remained significant when globally sclerotic glomeruli were included in the calculation of the GD. Of note, the GD in HNS patients with overt proteinuria (≥1g/day) was significantly lower than that of HNS patients with mild proteinuria (2, P = 0.014). In contrast, other histopathological parameters, including the severity of global glomerulosclerosis, interstitial fibrosis/tubular atrophy and arterial and arteriole lesions were comparable between the 2 HNS subgroups. In addition, the GD was identified as a factor that was associated with the amount of urinary protein excretion at biopsy, independent of other clinicopathological factors. These results suggest that a low GD is a renal histological characteristic of HNS patients, especially those with overt proteinuria.
- 27 January 2015
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 28 (9) , 1164-1171
Open AccessGlomerular Density in Biopsy-Proven Hypertensive Nephrosclerosis
Previous autopsy studies suggested that a reduced nephron number is associated with increased risk of hypertension and chronic kidney disease. However, the significance of the nephron number estimated from a renal biopsy in patients with hypertensive nephrosclerosis (HNS) has not yet been elucidated. In this cross-sectional study, we examined the clinicopathological findings of biopsy-proven HNS patients with preserved renal function (estimated glomerular filtration rate ≥ 60ml/min/1.73 m2). The glomerular density (GD; the number of glomeruli per total renal cortical area) in biopsy specimens was evaluated as a surrogate of the nephron number. Renal biopsies from kidney transplant donors were used as healthy controls. A total of 58 HNS patients were enrolled. The GD value in the HNS patients was low compared with those in the kidney transplant donors (2.0 vs. 3.2 /mm2). These differences remained significant when globally sclerotic glomeruli were included in the calculation of the GD. Of note, the GD in HNS patients with overt proteinuria (≥1g/day) was significantly lower than that of HNS patients with mild proteinuria (2, P = 0.014). In contrast, other histopathological parameters, including the severity of global glomerulosclerosis, interstitial fibrosis/tubular atrophy and arterial and arteriole lesions were comparable between the 2 HNS subgroups. In addition, the GD was identified as a factor that was associated with the amount of urinary protein excretion at biopsy, independent of other clinicopathological factors. These results suggest that a low GD is a renal histological characteristic of HNS patients, especially those with overt proteinuria.